Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin
Josephine F. TrottKatherine C HoriganJulia M. GloviczkiKristen M CostaB. A. FrekingC. FarmerKanako HayashiThomas E. SpencerJoseph MorabitoRussell C. Hovey
35
Citation
82
Reference
10
Related Paper
Citation Trend
Abstract:
Prolactin (PRL) acts through its receptor (PRLR) via both endocrine and local paracrine/autocrine pathways to regulate biological processes including reproduction and lactation. We analyzed the tissue- and stage of gestation-specific regulation of PRL and PRLR expression in various tissues of pigs. Abundance of p PRLR -long form (LF) mRNA increased in the mammary gland and endometrium during gestation while in other tissues it remained constant. There was a parallel increase in the abundance of the pPRLR-LF protein in the mammary gland and endometrium during gestation. We determined the hormonal regulation of p PRLR -LF mRNA expression in various tissues from ovariectomized, hypoprolactinemic gilts given combinations of the replacement hormones estrogen (E 2 ), progestin (P), and/or haloperidol-induced PRL. Abundance of p PRLR -LF mRNA in kidney and liver was unaffected by hormone treatments. Expression of uterine p PRLR -LF mRNA was induced by E 2 whereas the effect of E 2 was abolished by co-administering P. The expression of p PRLR -LF mRNA in the mammary gland stroma was induced by PRL, whereas E 2 induced its expression in the epithelium. In contrast to these changes in p PRLR expression, p PRL expression was relatively constant and low during gestation in all tissues except the pituitary. Taken together, these data reveal that specific combinations of E 2 , P, and PRL differentially regulate pPRLR-LF expression in the endometrium and mammary glands, and that the action of PRL on its target tissues is dependent upon pPRLR-LF abundance more so than the local PRL expression.Keywords:
Prolactin receptor
Cell fate determination
Single-Cell Analysis
Cite
Citations (0)
Cite
Citations (6)
Autocrine and paracrine signaling mechanisms are traditionally difficult to study due to the recursive nature of the process and the sub-micromolar concentrations involved. This has proven to be especially limiting in the study of embryonic stem cells that might rely on such signaling for viability, self-renewal, and proliferation. To better characterize possible effects of autocrine and paracrine signaling in the setting of expanding stem cells, we developed a computational model assuming a critical need for cell-secreted survival factors. This model suggested that the precise way in which the removal of putative survival factors could affect stem cell survival in culture. We experimentally tested the predictions in mouse embryonic stem cells by taking advantage of a novel microfluidic device allowing removal of the cell-conditioned medium at defined time intervals. Experimental results in both serum-containing and defined N2B27 media confirmed computational model predictions, suggested existence of unknown survival factors with distinct rates of diffusion, and revealed an adaptive/selective phase in mouse embryonic stem cell response to a lack of paracrine signaling. We suggest that the described computational/experimental platform can be used to identify and study specific factors and pathways involved in a wide variety of paracrine signaling systems.
Cite
Citations (40)
It was reported that autocrine and paracrine of cytokines play a central role in the pathogenesis of glomeru-
lonephritis(GN)and glomerulosclerosis(GS).previous studies demanstrated that IL—1 like factor is not only
produced by MSc,but also stimulates MSc proliferation.In order to examine the autocrine and paracrine of IL
—1 in MSc in molecular biologic level,we explored the effects of rIL—1 on MSc IL—1 and TGFB mRNA gene
expression.Total RNA was extracted from subcultured MSc in presence of absence of rIL-1 in 3,6,12,hours
and dot blots.The MSc proiferation was a dose dependent of rIL—1,and IL—1 promoted MSc IL—1 and
TGFB mRNA gene expression.Our results support the possible role of IL—1 autocrine and paracine in MSc.
Northern blot
Cite
Citations (0)
Autocrine and paracrine signaling in the kidney adds an extra level of diversity and complexity to renal physiology. The extensive scientific production on the topic precludes easy understanding of the fundamental purpose of the vast number of molecules and systems that influence the renal function. This systematic review provides the broader pen strokes for a collected image of renal paracrine signaling. First, we recapitulate the essence of each paracrine system one by one. Thereafter the single components are merged into an overarching physiological concept. The presented survey shows that despite the diversity in the web of paracrine factors, the collected effect on renal function may not be complicated after all. In essence, paracrine activation provides an intelligent system that perceives minor perturbations and reacts with a coordinated and integrated tissue response that relieves the work load from the renal epithelia and favors diuresis and natriuresis. We suggest that the overall function of paracrine signaling is reno-protection and argue that renal paracrine signaling and self-regulation are two sides of the same coin. Thus local paracrine signaling is an intrinsic function of the kidney, and the overall renal effect of changes in blood pressure, volume load, and systemic hormones will always be tinted by its paracrine status.
Cite
Citations (21)
Breast development
Cite
Citations (19)
Antiangiogenic agents block the effects of tumor-derived angiogenic factors (paracrine factors), such as vascular endothelial growth factor (VEGF), on endothelial cells (EC), inhibiting the growth of solid tumors. However, whether inhibition of angiogenesis also may play a role in liquid tumors is not well established. We recently have shown that certain leukemias not only produce VEGF but also selectively express functional VEGF receptors (VEGFRs), such as VEGFR-2 (Flk-1, KDR) and VEGFR1 (Flt1), resulting in the generation of an autocrine loop. Here, we examined the relative contribution of paracrine (EC-dependent) and autocrine (EC-independent) VEGF/VEGFR signaling pathways, by using a human leukemia model, where autocrine and paracrine VEGF/VEGFR loops could be selectively inhibited by neutralizing mAbs specific for murine EC (paracrine pathway) or human tumor (autocrine) VEGFRs. Blocking either the paracrine or the autocrine VEGF/VEGFR-2 pathway delayed leukemic growth and engraftment in vivo , but failed to cure inoculated mice. Long-term remission with no evidence of disease was achieved only if mice were treated with mAbs against both murine and human VEGFR-2, whereas mAbs against human or murine VEGFR-1 had no effect on mice survival. Therefore, effective antiangiogenic therapies to treat VEGF-producing, VEGFR-expressing leukemias may require blocking both paracrine and autocrine VEGF/VEGFR-2 angiogenic loops to achieve remission and long-term cure.
Cite
Citations (275)
Cite
Citations (62)
Summary Chronic lymphocytic leukaemia (CLL) is characterized by the accumulation of long‐lived B lymphocytes blocked in G 0/1 by impaired apoptosis. As insulin‐like growth factor‐I (IGF‐I) is known for its antiapoptotic effects in different cell types, we investigated whether IGF‐I and its receptor (IGF‐IR) participate in autocrine/paracrine loops affecting the survival of CLL cells. IGF‐IR protein and mRNA was present in CLL cells in 44% and 59% of patients respectively. IGF‐IR expression in CLL patients was positively correlated with the expression of the antiapoptotic protein Bcl‐2 and was involved in CLL cell survival in vitro . Serum IGF‐I was elevated in CLL patients, but growth hormone (GH) was normal. CLL cells expressed IGF‐I mRNA and secreted the growth factor in vitro . Therefore, local production of IGF‐I can account for the increased levels of serum IGF‐I, independently of GH, and may be related to autocrine/paracrine control of lymphocyte survival acting at IGF‐IR. This is the first demonstration of IGF‐IR expression in a subgroup of CLL patients and of its antiapoptotic effects in vitro , highlighting the importance of this growth factor receptor as a possible therapeutic target in CLL.
Cite
Citations (34)
Parathyroid hormone-related protein
Northern blot
Cite
Citations (16)